Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...

HKU State Key Laboratory for Emerging Infectious Diseases and InnoHK Centre for Virology, Vaccinology and Therapeutics Successfully Develop Nasal ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) reported 15 more H5N1 avian flu ...

Since 1959 the avian flu virus H5N1 has been popping up around the globe. Now scientists believe it could spark the next ...